- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03124186
Sensory-driven Motor Recovery in Poorly Recovered Subacute Stroke Patients
September 8, 2023 updated by: Lumy Sawaki
This research project addresses a scientifically important question that cannot be answered by other means.
The use of peripheral nerve stimulation has the potential to enhance recovery in subacute stroke patients with poor functional recovery.
The primary objective of this proposal is to demonstrate that peripheral nerve stimulation combined with intensive motor training has the ability to further improve hand motor function when compared to intensive training alone or nerve stimulation alone.
The results from this study have the potential to develop new strategies in neurorehabilitation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Stroke is the leading cause of long-term disability in the United States.
Approximately 70-88% of persons with ischemic stroke have some degree of motor impairment.
A major goal of research in stroke rehabilitation is to harness the ability of the brain to reorganize after neurologic damage has occurred and thus ultimately lead to successful recovery of function.
Data from animal and human models have suggested that sensory input plays an important role in motor output, possibly by influencing cortical plasticity.
However, in spite of the advances to date, little is known about the extent to which sensory input in the form of peripheral nerve stimulation (PNS) can be successfully combined to physical training, especially in poorly recovered subacute stroke patients.
The proposed study will evaluate the effectiveness of sustained PNS coupled with motor training, to improve hand motor function in subacute stroke patients with severe motor deficit.
Our preliminary data in chronic stroke patients with severe motor deficit demonstrate that motor function can be substantially enhanced when PNS is paired with motor training.
In addition, a separate study in patients with mild motor deficit receiving motor training alone suggests that the optimal therapeutic time window to deliver motor training is within the first year after stroke.
The improvement of behavioral motor function was associated with corticomotor reorganization.
Therefore, this study proposes to evaluate the effectiveness of sustained PNS paired with motor training, to promote functional motor recovery in subacute stroke patients with severe motor deficit.
The central hypothesis is that subacute stroke patients with severe motor deficit receiving PNS and intensive task-oriented therapy will have improved motor function compared to patients receiving sham-PNS and task-oriented therapy, and the degree of this behaviorally-measured effect will correlate with the neurophysiological effect measured by transcranial magnetic stimulation.
The investigators plan to accept or reject the central hypothesis by accomplishing two Specific Aims: 1) test the effect of PNS preceding task-oriented therapy on hand motor function, and 2) test the effect of PNS preceding task-oriented therapy on motor map measured by transcranial magnetic stimulation.
The long-range goals are: a) to maximize the restoration of hand motor function after stroke, b) to determine the impact of this intervention in activities of daily living, and c) collect solid data to prepare for a future multicenter randomized clinical trial.
Study Type
Interventional
Enrollment (Actual)
73
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Having sustained a single ischemic or hemorrhagic stroke during the 3- to 12-month period preceding enrollment
- Single stroke
- Inability at the time of screening to demonstrate active extension of the affected metacarpophalangeal and interphalangeal joints at least 10°; and the wrist, 20° (ie, level of impairment that would preclude participation in constraint-induced therapy)
- Score of 47 or lower on the modified 30-item Fugl-Meyer Assessment of UE motor function
- Participants NOT able to extend the affected metacarpophalangeal joints at least 10° and the wrist 20°.
Exclusion Criteria:
- History of carpal tunnel syndrome and conditions that commonly cause peripheral neuropathy, including diabetes, uremia, or associated nutritional deficiencies
- History of head injury with loss of consciousness, severe alcohol or drug abuse, psychiatric illness
- Within 3 months of recruitment, use of drugs known to exert detrimental effects on motor recovery
- Cognitive deficit severe enough to preclude informed consent
- Positive pregnancy test or being of childbearing age and not using appropriate contraception
- Participants with history of untreated depression.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Active stimulation with motor training
2 hours of active peripheral nerve stimulation (intervention) paired with 4 hours of intensive task-oriented upper extremity training.
Peripheral nerve stimulation of Erb's point, radial and median nerves paired with task-oriented therapy.
Peripheral nerve stimulation will be delivered using a S88 Dual Output Stimulator by Grass Technologies.
|
Peripheral nerve stimulation of Erb's point, radial and median nerves paired with task-oriented therapy
|
|
Active Comparator: Sham stimulation with motor training
2 hours of sham peripheral nerve stimulation (intervention) paired with 4 hours of intensive task-oriented upper extremity training.
Peripheral nerve stimulation of Erb's point, radial and median nerves paired with task-oriented therapy.
Peripheral nerve stimulation will be delivered using a S88 Dual Output Stimulator by Grass Technologies.
|
Peripheral nerve stimulation of Erb's point, radial and median nerves paired with task-oriented therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Fugl Meyer Assessment
Time Frame: Score change after 18 days of intervention compared to baseline; Score change after 1- and 4-month after the intervention compared to baseline
|
The upper extremity FMA is a quantitative measure of motor recovery, sensation, coordination, and speed.
|
Score change after 18 days of intervention compared to baseline; Score change after 1- and 4-month after the intervention compared to baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Action Arm Research Test (ARAT)
Time Frame: Score change after 18 days of intervention compared to baseline; Score change after 1- and 4-month after the intervention compared to baseline
|
The ARAT was developed specifically to measure UE changes and consists of 4 specific tests to measure grasp, grip, pinch, and gross movement.
|
Score change after 18 days of intervention compared to baseline; Score change after 1- and 4-month after the intervention compared to baseline
|
|
Change in Wolf Motor Function Test (WMFT)
Time Frame: Score change after 18 days of intervention compared to baseline; Score change after 1- and 4-month after the intervention compared to baseline
|
The WMFT is a time- and function-based evaluation encompassing a battery of 17 tasks
|
Score change after 18 days of intervention compared to baseline; Score change after 1- and 4-month after the intervention compared to baseline
|
|
Change in Stroke Impact Scale (SIS)
Time Frame: Score change after 18 days of intervention compared to baseline; Score change after 1- and 4-month after the intervention compared to baseline
|
The SIS is a self-report measure that includes 64 items assessing 8 domains including strength, hand function, ADL/IADL, mobility, communication, emotion, memory and thinking, and participation.
|
Score change after 18 days of intervention compared to baseline; Score change after 1- and 4-month after the intervention compared to baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2008
Primary Completion (Actual)
June 30, 2013
Study Completion (Actual)
June 30, 2013
Study Registration Dates
First Submitted
April 18, 2017
First Submitted That Met QC Criteria
April 18, 2017
First Posted (Actual)
April 21, 2017
Study Record Updates
Last Update Posted (Actual)
September 11, 2023
Last Update Submitted That Met QC Criteria
September 8, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5R01HD056002 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
Clinical Trials on S88 Dual Output Stimulator by Grass Technologies
-
Lumy SawakiCompletedStroke | Cerebrovascular Accident
-
Vanderbilt University Medical CenterRecruiting
-
Vanderbilt University Medical CenterEnrolling by invitation